Harvard Bioscience
HBIO
HBIO
74 hedge funds and large institutions have $87.4M invested in Harvard Bioscience in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 77 → 74 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
74
Holding in Top 10
2
Calls
$19K
Puts
$20K
Top Buyers
| 1 | +$4.56M | |
| 2 | +$2.61M | |
| 3 | +$1.78M | |
| 4 |
KAM
Knightsbridge Asset Management
Newport Beach,
California
|
+$969K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$694K |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$1.7M | |
| 3 | -$182K | |
| 4 |
CSM
Central Square Management
Naperville,
Illinois
|
-$156K |
| 5 |
Morgan Stanley
New York
|
-$135K |